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1. Introduction
Receiving a cancer diagnosis is very disheartening, but hearing a diagnosis for a child takes 
on a whole new set of knowledge and emotions. Pediatric cancers (ages 0–19) are a rare and 
challenging time for families, as well as for pediatricians and oncologists. While cancer is 
much less common among children compared to adults, 1 in 285 children will be diagnosed 
with the disease before the age of 20 years in the United States [2]. The incidence rate of pedi-
atric cancers in the United States has increased slightly over the years (0.6% per year [2]), but 
rates of a 5-year survival for many of these cancer types have increased to an even greater 
degree due to advances in modern technology. For most cases, the cause of a childhood cancer 
is inconclusive, and gathering sound data in the area is challenging because pediatric cancers 
are so rare. From what researchers have been able to gather, there have been links between 
certain gene mutations passed from mother to child as well as an increased risk in children 
who experience gene changes during early growth in the womb [1].
There is a slight variability in pediatric characteristics relating to incidence rates and survival. 
These differences can be seen in sex, ethnicity, and age, but the reasons behind these vari-
ances are not well understood. While the rates of 5-year survivors are similar, incidence and 
mortality rates tend to be lower in girls than in boys. Conversely, in adolescents, incidence 
rates are similar and girls have lower mortality rates compared to boys [2]. There is even more 
variability when looking at ethnic background. Caucasian and Hispanic children have the 
highest incidence rates for developing cancer compared to African American children who 
have the lowest incidents rates but experience the lowest survival rates as well [3]. Children 
with Down syndrome are also at an increased risk of developing leukemia [1].
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2. Differences in pediatric and adult cancers
Types of cancers that develop in child and adolescent populations differ from the adult popula-
tion in several ways. The most prevalent types of cancers seen in children are leukemia (26%), 
cancers of the brain and central nervous systems (18%), and lymphoma (14%) [4]. These cancers 
are typically only seen in child populations, and this is due to the embryonic or developmental 
nature of the cancer origin. Since these cancers develop either while in-utero or develop from 
embryonic tissue, these cancers are rarely seen in adult populations. Those diagnosed closer to 
adolescence tend to reflect similar cancers to that of the adult population. Pediatric cancers are 
often the result of DNA mutations that happen very early in life (sometimes even before birth) 
and are not strongly linked to lifestyle or environmental cancers the way adult populations are 
[5].
Treatment mechanisms also differ in pediatric and adult populations. Some treatments given 
to adults are deemed unsafe for children due to their destructive nature [1]. Many times, 
pediatric cancers are handled with a team of experts, or the child’s oncology group (COG), in 
order to determine the best routes of health care [1].
3. Types of childhood cancers
Pediatric cancers represent 1% of all new cancer cases, but these cancers are usually fast 
developing and require multidisciplinary teams including pediatric oncologists, surgeons, 
radiation oncologists, and other specialists [5]. Cancers in the pediatric populations can be 
further divided into common types of cancer affecting children (ages 0–14) and adolescents 
(ages 15–19). The most common cancer types for children are lymphocytic leukemia, brain 
and central nervous system, neuroblastoma, and non-Hodgkin’s lymphoma, while adoles-
cents are more commonly diagnosed with Hodgkin’s lymphoma and thyroid carcinoma 
[2, 5].
Similar to adult populations, pediatric cancer treatments come accompanied with many harsh 
side effects. Milder side effects can include rash, pain, and upset stomach and can usually be 
eased with medication and healthy living [1]. Cancer can affect these children very early in 
life, sometimes interrupting the natural growth and development processes. Harsher side 
effects experienced with treatment can interrupt or halt the natural development in organs 
and tissues, changing their function [1, 5].
4. Prevention, treatment, and outcomes
Obtaining sound data in terms of prevention has been found to be difficult as pediatric cancers 
are so rare, and many prevention mechanisms would be attributed to womb development. 
What is known regarding prevention is that there is a lack of control in terms of reducing the 
risk of incidence. Research has shown that physical activity and proper nutrition (to name a 
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few) can improve treatment and survivorship parameters, but there has been little progress 
in terms of prevention [6].
For most cancer types in the pediatric community, the treatment option that tends to respond 
best is chemotherapy. Children are often able to handle higher doses of chemo drugs for shorter 
periods of time [1]. In addition, children’s bodies are better capable of handling chemotherapy 
treatments than adults. Radiation treatment is also an option for pediatric cancers, but children 
(especially very young children) are more likely to be affected negatively, and radiation ther-
apy can lead to potential long-term side effects that can be experienced later in life. As pediatric 
cancers affect children at a young age, along with there being an increase in survivors, manage-
ment and frequent follow-up care are important.
5. Conclusion
Within the content of the following chapters, these topics and points will be discussed in more 
detail. The information found within this book will enhance professionals’ knowledge in the 
field of pediatric oncology and provide a sounder outlook for incidence, prevention, treat-
ment, and outcomes. Although further research needs to be done in this area for more specific 
knowledge to be gained, this book is filled with the most up-to-date information in the field 
of pediatric oncology thus far.
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